Publications by authors named "Peter D Cole"

Claim this Profile
T
The effects of doxorubicin on blood-brain barrier integrity in hCMEC/D3.
Chadni Patel, Christina Glytsou, Mi-Hyeon Jang, Peter D Cole

Neurotoxicology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia.
Yongkyu Park, Nirajan K C, Jeremy Willekens, Chadni Patel, Beth A Savage, Peter D Cole

Cancer Epidemiol Biomarkers Prev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Neurocognitive Functioning Among Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana Farber Cancer Institute ALL Consortium Study 16-001.
Sameera Ramjan, Melanie Blair Thies, Yuelin Li, Alexandra Thrope, Lewis Silverman, Peter D Cole

Pediatr Blood Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin causes cognitive impairment and alters gut microbiota in both male and female juvenile rats.
Chadni Patel, Jeremy Willekens, Frank Diglio, Peter D Cole

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia.
Elena J Ladas, Haiyang Sheng, Uma H Athale, Barbara L Asselin, Luis A Clavell, Peter D Cole

JAMA Netw Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Utilizing a Brief Neurocognitive Battery in 3-Year-Old Patients During Treatment for Acute Lymphoblastic Leukemia.
Sameera Ramjan, Peter D Cole, Melanie Blair-Thies, Lewis B Silverman, Amy Fredrickson

Pediatr Blood Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical Trial.
Stephen Daw, Peter D Cole, Bradford S Hoppe, David Hodgson, Auke Beishuizen

JAMA Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment.
Michelle C Janelsins, Kathleen Van Dyk, Sheri J Hartman, Thuy T Koll, Christina K Cramer, Peter D Cole

J Natl Cancer Inst· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort.
Rahela Aziz-Bose, Colin Cernik, Puja J Umaretiya, Lenka Ilcisin, Colleen A Kelly, Peter D Cole

Pediatr Blood Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia.
Qianqian Zhu, Ram Nambiar, Emily Schultz, Xinyu Gao, Shuyi Liang, Peter D Cole

Br J Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Response and Subgroup Analyses to Support Body Weight-Based Dosing of Brentuximab Vedotin in Children and Young Adults with Newly Diagnosed High-risk Classical Hodgkin Lymphoma.
Zufei Zhang, Daping Zhang, Wenchuan Guo, Keenan Fenton, Sujata Narayanan, Peter D Cole

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis.
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Zinzani, Ann S LaCasce, Peter D Cole

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tau, Glial Fibrillary Acidic Protein, and Neurofilament Light Chain as Brain Protein Biomarkers in Cerebrospinal Fluid and Blood for Diagnosis of Neurobiological Diseases.
Yongkyu Park, Nirajan Kc, Alysta Paneque, Peter D Cole

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemobrain: An accelerated aging process linking adenosine A receptor signaling in cancer survivors.
Alfredo Oliveros, Michael Poleschuk, Peter D Cole, Detlev Boison, Mi-Hyeon Jang

Int Rev Neurobiol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inequitable Poverty Exposures: A Subspecialty Opportunity to Address Disparities.
Kristine A Karvonen, Puja J Umaretiya, Victoria B Koch, Yael Flamand, Rahela Aziz-Bose, Peter D Cole

Hosp Pediatr· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive function.
Mohammad Abdur Rashid, Jason J Tang, Ki-Hyun Yoo, Ana Corujo-Ramirez, Alfredo Oliveros, Peter D Cole

Front Mol Neurosci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia.
Puja J Umaretiya, Victoria B Koch, Yael Flamand, Rahela Aziz-Bose, Lenka Ilcisin, Peter D Cole

J Natl Cancer Inst· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of chest x-ray- and CT-defined large mediastinal adenopathy in high-risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831.
Andrea C Lo, Inki Lee, Qinglin Pei, Yue Wu, Kathleen M McCarten, Peter D Cole

Pediatr Blood Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study.
Sarah A Milgrom, Jihyun Kim, Qinglin Pei, Inki Lee, Bradford S Hoppe, Peter D Cole

Br J Haematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.
Paul Harker-Murray, Christine Mauz-Körholz, Thierry Leblanc, Maurizio Mascarin, Gérard Michel, Peter D Cole

Blood· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of serial neurocognitive assessment using Cogstate during and after therapy for childhood leukemia.
Peter D Cole, Soo Young Kim, Yuelin Li, Adrian Schembri, Kara M Kelly

Support Care Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race, Neighborhood Opportunity, and Life-Threatening Complications in Children With Cancer: A Moderated Mediation Approach.
Beth Savage, Peter D Cole, Haiqun Lin

Cancer Nurs· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium.
Justine M Kahn, Kristen Stevenson, Melissa Beauchemin, Victoria B Koch, Peter D Cole

J Pediatr Hematol Oncol Nurs· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of oncology clinical trial-embedded evaluation of social determinants of health.
Rahela Aziz-Bose, Daniel J Zheng, Puja J Umaretiya, Lenka Ilcisin, Kristen Stevenson, Peter D Cole

Pediatr Blood Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable remission for four pediatric patients with high-risk relapsed classical Hodgkin lymphoma treated with brentuximab vedotin plus gemcitabine but without autologous stem cell transplantation: A report from the Children's Oncology Group.
Ilia N Buhtoiarov, Nkechi I Mba, Crystal D L Santos, Kathleen M McCarten, Monika L Metzger, Peter D Cole

Pediatr Blood Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis